Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice. Ann Med Res . 2026;33(5):192-198. Accessed June 1, 2026. http://www.annalsmedres.org/index.php/aomr/article/view/4909